Latest News
Alaunos Therapeutics, Inc.
- Alaunos buys Velaris, raises $350m for lung drugs
- Which of Alaunos Therapeutics (NASDAQ:TCRT), JBDI Holdings (NASDAQ:JBDI), Picard Medical (NYSEAMERICAN:PMI) or NetApp (NASDAQ:NTAP) Is the Most Overbought Name on Wednesday's Pre-Market List, With an RSI Above 75?
- Alaunos pivots to PAH with Velaris acquisition and USD 350m financing
- Alaunos Therapeutics lands $350M private placement led by Fairmount
- Alaunos acquires Velaris Therapeutics
- Alaunos lands Paragon-built pulmonary hypertension pipeline via Velaris merger
- Alaunos Therapeutics Acquires Velaris Therapeutics, Secures $350M Private Placement
- Alaunos Therapeutics Buys Velaris Therapeutics On October 13
- Alaunos Therapeutics Announces Acquisition of Velaris Therapeutics
- Alaunos Therapeutics Completes Velaris Acquisition; Shares Surge
- Paragon Labs Expands Leadership Team with Former Apogee Executives; Velaris Therapeutics Acquired by Alaunos Therapeutics, Inc.
- Alaunos completes Velaris acquisition, raises $350 million By Investing.com
Headlines from the last 30 days, linking to the original publishers. See all market news →